2008
DOI: 10.1179/crn.2008.014
|View full text |Cite
|
Sign up to set email alerts
|

Different Substances and Dry-Needling Injections in Patients with Myofascial Pain and Headaches

Abstract: Trigger point injections with different solutions have been studied mainly with regard to the management of myofascial pain (MFP) patient management. However, few studies have analyzed their effect in a chronic headache population with associated MFP. The purpose of this study was to assess if trigger point injections using lidocaine associated with corticoid would be better than lidocaine alone, as in comparison with dry-needling in for the management of local pain and associated headache management. Forty-fi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
26
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 77 publications
(26 citation statements)
references
References 28 publications
0
26
0
Order By: Relevance
“…Detection of higher concentrations of bradykinin, CGRP, substance P, TNF-α, IL-1b, serotonin, and norepinephrine during histopathological examinations suggested the role of trigger points in the pathogenesis of chronic TTH by these mediators [24]. Although the trigger points used in the treatment of primary headaches differ partially among individual patients, they are frequently localized on the trapezius muscle, posterior cervical paraspinal muscles, suboccipital muscles, and sternocleidomastoid muscles [25]. In our study, myofascial trigger points localized on muscles innervated by the C1-C3 vertebral nerves and trigeminal nerve (temporal, masseter, sternocleidomastoid, and posterior cervical paraspinal muscles) were used both in the control and study groups.…”
Section: Discussionmentioning
confidence: 99%
“…Detection of higher concentrations of bradykinin, CGRP, substance P, TNF-α, IL-1b, serotonin, and norepinephrine during histopathological examinations suggested the role of trigger points in the pathogenesis of chronic TTH by these mediators [24]. Although the trigger points used in the treatment of primary headaches differ partially among individual patients, they are frequently localized on the trapezius muscle, posterior cervical paraspinal muscles, suboccipital muscles, and sternocleidomastoid muscles [25]. In our study, myofascial trigger points localized on muscles innervated by the C1-C3 vertebral nerves and trigeminal nerve (temporal, masseter, sternocleidomastoid, and posterior cervical paraspinal muscles) were used both in the control and study groups.…”
Section: Discussionmentioning
confidence: 99%
“…42 Dry needling is often used to treat myofascial trigger points (MTrPs), which are described as localized hypersensitive spots in a palpable taut band of muscle. These hyperirritable spots can be classified as active MTrPs when they produce spontaneous pain and, when palpated, reproduce a patient's familiar pain.…”
mentioning
confidence: 99%
“…It is believed that the high percentage (100%) of patients with pain in some region of the face and/or neck occurred because of this study being specifically for the assessment of pain in this region; pain in this region is often not observed due to the lack of emphasis given by the examiner, mainly when the pain is not just a localized problem but rather a condition with generalized muscle pain like FM 10 . In these patients, sensitivity in the temporal muscle was identified by the reporting of pain at the temples or above the ears, confirming a high pain sensitivity in the temporal muscle of patients with MPS 7 . The strong presence of MMPS as well as headache confirmed the association of FM with other conditions.…”
Section: Discussionmentioning
confidence: 54%
“…Myofascial pain syndrome (MPS) is a common regional pain syndrome, considered to be the complaint of pain most present in medical practice. The painful symptoms are the result of hyperalgesia of small trigger points, which radiate pain to distant sites 6,7 . MPS can affect the orofacial region, and called masticatory myofascial pain syndrome (MMPS).…”
mentioning
confidence: 99%